Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Life Sciences
Neural Changes Associated With Rewards And Punishment Following Ego Depletion Or Boredom, Travis Z. Johnson, Michael Larson, Marina Milyavskaya, Michael Inzlicht
Neural Changes Associated With Rewards And Punishment Following Ego Depletion Or Boredom, Travis Z. Johnson, Michael Larson, Marina Milyavskaya, Michael Inzlicht
FHSS Mentored Research Conference
Our brain power is exhaustible. We are constantly trying to find ways to perform at our highest levels. There has been research that has shown that willpower--the capacity to exert self-control--is a limited resource that is depleted after exertion of the brain. Many studies have shown the negative effect that depletion has on daily decisions. Depletion can influence our day-to-day choices and actions in a variety of important ways. The neural mechanisms for ego-depletion are relatively unknown so our purpose is to measure the effects of ego-depletion, and then test ways that it can be decreased or reversed, thus finding …
Treatment Of Diabetic Neuropathy With Nitric Oxide Gel, Daniel R. Lathen, David Walton, Yukino Strong, Jeff Ward, Conner Sugrue, Jonathan Trout, Devin Vanderwood, Alonzo Cook Ph.D.
Treatment Of Diabetic Neuropathy With Nitric Oxide Gel, Daniel R. Lathen, David Walton, Yukino Strong, Jeff Ward, Conner Sugrue, Jonathan Trout, Devin Vanderwood, Alonzo Cook Ph.D.
FHSS Mentored Research Conference
Our study investigates a novel therapy to address a vascular factor that contributes to the development of diabetic peripheral neuropathy (DPN) using five experimental groups of a mouse model that spontaneously develops diabetes. The compound under investigation is a nitric oxide (NO)-donating topical gel which has potential as a treatment for preventing and treating DPN.
Pams: A Growing Field In Pharmacological Drug Development, Marcel Hall, J. Kolb, B. Todd Jr., D. Pugh, B. Vance, B. Klienstuber, R. Drecketts, Doris Jackson, H. R. Arias, S. N. Sudweeks
Pams: A Growing Field In Pharmacological Drug Development, Marcel Hall, J. Kolb, B. Todd Jr., D. Pugh, B. Vance, B. Klienstuber, R. Drecketts, Doris Jackson, H. R. Arias, S. N. Sudweeks
FHSS Mentored Research Conference
Positive Allosteric Modulators (PAMs) are a growing field in pharmacology. PAM-5 and genisteincause acetylcholine (ACh) to elicit larger currents on nicotinic acetylcholine receptors (nAChRs) without activating the channel themselves. In effect, PAMs increase the amplitude of currents at a synapse without altering the normal firing rate of the neurons.
Novel Pharmacological Target: Characterization Of A3b2 Nachrs Expressed In Xenopus Laevis Oocytes, Doris Jackson, Marcel Hall, J. Kolb, B. Todd Jr., D. Pugh, B. Vance, B. Klienstuber, R. Drecketts, S. N. Sudweeks
Novel Pharmacological Target: Characterization Of A3b2 Nachrs Expressed In Xenopus Laevis Oocytes, Doris Jackson, Marcel Hall, J. Kolb, B. Todd Jr., D. Pugh, B. Vance, B. Klienstuber, R. Drecketts, S. N. Sudweeks
FHSS Mentored Research Conference
We have identified two subtypes of the novel a3b2 nicotinic acetylcholine receptor (nAChR) found within interneurons of the hippocampus. This novel receptor may be a valuable pharmacological target in drug development for disease such as Alzheimer’s disease (AD) which is largely characterized by degeneration of the hippocampus.